Downregulation of CD44 reduces doxorubicin resistance of CD44⁺CD24⁻ breast cancer cells

References

• Antón AparicioLMCassinello EspinosaJGarcía CampeloRGómez VeigaFDíaz PradoSAparicio GallegoGProstate carcinoma and stem cellsClin Transl Oncol200792667617329217
   PubMed Web of Science ®Google Scholar
• EramoALottiFSetteGIdentification and expansion of the tumorigenic lung cancer stem cell populationCell Death Differ200815350451418049477
   PubMed Web of Science ®Google Scholar
• GlinskyGVStem cell origin of death-from-cancer phenotypes of human prostate and breast cancersStem Cell Rev200731799317873385
   PubMed Web of Science ®Google Scholar
• LiCHeidtDGDalerbaPIdentification of pancreatic cancer stem cellsCancer Res20076731030103717283135
   PubMed Web of Science ®Google Scholar
• PrinceMESivanandanRKaczorowskiAIdentification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinomaProc Natl Acad Sci U S A2007104397397817210912
   PubMed Web of Science ®Google Scholar
• SeoDCSungJMChoHJGene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cellsMol Cancer200767518034892
   PubMed Web of Science ®Google Scholar
• Al-HajjMWichaMSBenito-HernandezAMorrisonSJClarkeMFProspective identification of tumorigenic breast cancer cellsProc Natl Acad Sci U S A200310073983398812629218
   PubMed Web of Science ®Google Scholar
• Ahmed-BelkacemAPozzaAMacalouSPérez-VictoriaJMBoumendjelADi PietroAInhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2)Anticancer Drugs200617323924316520651
   PubMed Web of Science ®Google Scholar
• CalcagnoAMFostelJMToKKSingle-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changesBr J Cancer20089891515152418382425
   PubMed Web of Science ®Google Scholar
• LagasJSvan der KruijssenCMvan de WeteringKBeijnenJHSchinkelAHTransport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromaroneDrug Metab Dispos200937112913618845662
   PubMed Web of Science ®Google Scholar
• LouHDeanMTargeted therapy for cancer stem cells: the patched pathway and ABC transportersOncogene20072691357136017322922
   PubMed Web of Science ®Google Scholar
• LvHHeZLiuXYuanJYuYChenZReversal of BCRP-mediated multidrug resistance by stable expression of small interfering RNAsJ Cell Biochem20071021758117372930
   PubMed Web of Science ®Google Scholar
• PriebschARompeFTönniesHComplete reversal of ABCG2- depending atypical multidrug resistance by RNA interference in human carcinoma cellsOligonucleotides200616326327416978089
   PubMedGoogle Scholar
• AdamiaSMaxwellCAPilarskiLMHyaluronan and hyaluronan synthases: potential therapeutic targets in cancerCurr Drug Targets Cardiovasc Haematol Disord20055131415720220
   PubMedGoogle Scholar
• CalcagnoAMSalcidoCDGilletJPProlonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristicsJ Natl Cancer Inst2010102211637165220935265
   PubMedGoogle Scholar
• FillmoreCMKuperwasserCHuman breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapyBreast Cancer Res2008102R2518366788
   PubMed Web of Science ®Google Scholar
• LacerdaLPusztaiLWoodwardWAThe role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approachesDrug Resist Updat2010134–59910820739212
   PubMed Web of Science ®Google Scholar
• VerkaikNSTrapmanJRomijnJCVan der KwastTHVan SteenbruggeGJDown-regulation of CD44 expression in human prostatic carcinoma cell lines is correlated with DNA hypermethylationInt J Cancer19908034394439935187
   PubMed Web of Science ®Google Scholar
• AruffoAStamenkovicIMelnickMUnderhillCBSeedBCD44 is the principal cell surface receptor for hyaluronateCell1990617130313131694723
   PubMed Web of Science ®Google Scholar
• JinLHopeKJZhaiQSmadja-JoffeFDickJETargeting of CD44 eradicates human acute myeloid leukemic stem cellsNat Med200612101167117416998484
   PubMed Web of Science ®Google Scholar
• KrauseDSLazaridesKvon AndrianUHVan EttenRARequirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cellsNat Med200612101175118016998483
   PubMed Web of Science ®Google Scholar
• BarbourAPReederJAWalshMDFawcettJAntalisTMGotleyDCExpression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3Cancer Res200363488789212591743
   PubMed Web of Science ®Google Scholar
• WeberGFBronsonRTIlaganJCantorHSchmitsRMakTWAbsence of the CD44 gene prevents sarcoma metastasisCancer Res20026282281228611956084
   PubMed Web of Science ®Google Scholar
• YuQTooleBPStamenkovicIInduction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 functionJ Exp Med199718612198519969396767
   PubMed Web of Science ®Google Scholar
• PontaHShermanLHerrlichPACD44: from adhesion molecules to signalling regulatorsNat Rev Mol Cell Biol200341334512511867
   PubMed Web of Science ®Google Scholar
• DouJPanMWenPIsolation and identification of cancer stem-like cells from murine melanoma cell linesCell Mol Immunol20074646747218163959
   PubMed Web of Science ®Google Scholar
• HurtEMKawasakiBTKlarmannGJThomasSBFarrarWLCD44+CD24(−) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosisBr J Cancer200898475676518268494
   PubMed Web of Science ®Google Scholar
• WrightMHCalcagnoAMSalcidoCDCarlsonMDAmbudkarSVVarticovskiLBrca1 breast tumors contain distinct CD44+/CD24− and CD133+ cells with cancer stem cell characteristicsBreast Cancer Res2008101R1018241344
   PubMed Web of Science ®Google Scholar
• YangYMChangJWBladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cellsCancer Invest200826772573318608209
   PubMed Web of Science ®Google Scholar
• CollinsATBerryPAHydeCStowerMJMaitlandNJProspective identification of tumorigenic prostate cancer stem cellsCancer Res20056523109461095116322242
   PubMed Web of Science ®Google Scholar
• PatrawalaLCalhounTSchneider-BroussardRHighly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cellsOncogene200625121696170816449977
   PubMed Web of Science ®Google Scholar
• DalerbaPDyllaSJParkIKPhenotypic characterization of human colorectal cancer stem cellsProc Natl Acad Sci U S A200710424101581016317548814
   PubMed Web of Science ®Google Scholar
• SpillaneJBHendersonMACancer stem cells: a reviewANZ J Surg200777646446817501888
   PubMed Web of Science ®Google Scholar
• HenryJCParkJKJiangJmiR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell linesBiochem Biophys Res Commun2010403112012521055388
   PubMed Web of Science ®Google Scholar
• XieZChoongPFPoonLFInhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasionCancer Chemother Pharmacol200862694995718259754
   PubMed Web of Science ®Google Scholar
• YangKTangYHabermehlGKIczkowskiKAStable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivityBMC Cancer2010101620074368
   PubMed Web of Science ®Google Scholar